intern
travel
steadili
increas
last
decad
longer
wealthi
healthi
number
travel
reach
one
billion
first
time
continu
rise
mani
risk
factor
increas
likelihood
develop
travelrel
ill
review
focu
pulmonaryrel
infect
tabl
mani
ill
selflimit
result
common
pulmonari
virus
preval
worldwid
certain
circumst
travelrel
pulmonari
infect
seriou
potenti
fatal
implic
even
caus
epidem
air
travel
shown
effici
pulmonari
infect
transmit
data
suggest
risk
diseas
transmiss
symptomfre
passeng
within
aircraft
cabin
associ
sit
within
row
contagi
passeng
flight
time
h
associ
mainli
deriv
investig
inflight
transmiss
tuberculosi
tb
aircraft
cabin
ventil
appear
key
factor
enabl
diseas
transmiss
highlight
spread
sever
acut
respiratori
syndrom
sar
shorthaul
flight
sea
travel
especi
cruis
becom
popular
age
popul
travel
multipl
preexist
condit
also
concern
clinician
awar
particular
diseas
may
present
return
travel
rank
diagnost
likelihood
base
destin
length
stay
symptom
durat
tabl
pneumonia
frequent
caus
fever
amongst
return
travel
awar
travel
locat
may
key
identifi
organ
respons
polymeras
chain
reaction
pcr
test
import
look
atyp
etiolog
routin
patient
start
antibiot
base
local
guidelin
communityacquir
pneumonia
unlik
regimen
contain
appropri
firstlin
therapi
suffici
durat
cover
pneumonia
caus
coxiella
burnettii
q
fever
burkholderia
pseudomallei
melioidosi
isol
recent
outbreak
occur
europ
south
east
asia
pulmonari
infect
diagnos
return
travel
fever
make
common
travel
diarrhea
influenza
common
vaccineprevent
infect
acquir
vaccin
protect
two
influenza
b
viru
strain
pretravel
advic
travel
comorbid
vaccin
season
influenza
viru
pneumococcu
note
influenza
vaccin
current
offer
protect
recent
strain
caus
epidem
risk
acquir
ill
depend
season
travel
length
stay
affect
area
review
discuss
variou
pulmonari
infect
common
return
travel
clear
thorough
approach
symptomat
return
travel
essenti
skill
acutegener
physician
gener
practition
tabl
particular
attent
given
infect
may
spread
humantohuman
transmiss
clinician
awar
sourc
inform
suspect
travelrel
infect
concern
public
health
infect
relat
travel
constantli
evolv
import
clinician
remain
date
current
diseas
outbreak
manag
recommend
particular
attent
paid
travel
return
influenzaendem
area
take
account
newli
report
subtyp
burden
influenza
occur
winter
month
temper
region
northern
hemispher
novemb
april
southern
hemispher
april
octob
tropic
viru
circul
low
level
year
round
influenza
diagnos
viral
throat
swab
use
real
time
pcr
rtpcr
differenti
particular
influenza
subtyp
avian
influenza
subtyp
viru
caus
death
human
sinc
predomin
asia
north
east
africa
current
upsurg
case
egypt
octob
total
laboratoryconfirm
case
mortal
rate
recent
report
subtyp
first
diagnos
march
china
character
rapidli
progress
pneumonia
pulmonari
failur
acut
pulmonari
distress
syndrom
ard
octob
laboratoryconfirm
case
report
death
treatment
influenza
remain
controversi
topic
gener
support
manag
adopt
current
recommend
earli
administr
neuraminidas
inhibitor
eg
oseltamivir
affect
individu
close
contact
recent
metaanalysi
pandem
show
hospit
patient
treat
neuraminidas
inhibitor
lower
mortal
reduc
earli
instig
prevent
avian
influenza
prove
difficult
due
antigen
divers
circul
virus
hamper
vaccin
develop
healthcar
profession
take
postexposur
prophylaxi
eg
oseltamivir
patient
diagnos
avian
influenza
person
protect
equip
highli
recommend
like
influenza
viral
epidem
gather
public
heighten
awar
recognit
worldwid
mer
sar
zoonot
coronaviru
infect
regular
media
coverag
due
symptom
sever
associ
mortal
rate
anxieti
regard
potenti
humantohuman
transmiss
bat
thought
main
intermedi
host
virus
compel
evid
camel
also
respons
transmiss
mer
coronaviru
sar
first
report
atyp
pneumonia
world
health
organ
novemb
china
subsequ
spread
worldwid
first
report
epidem
occur
hong
kong
hotel
februari
viru
transmit
hotel
guest
stay
floor
infect
individu
viru
spread
intern
air
travel
thereaft
identifi
coronaviru
respons
nasopharyng
cultur
within
week
event
countri
report
affect
individu
confirm
case
worldwid
mortal
rate
pulmonari
symptom
associ
sar
typic
nonproduct
cough
subsequ
dyspnea
present
sever
day
initi
exposur
viru
sar
caus
airborn
viru
risk
transmiss
greatest
amongst
involv
direct
care
infect
individu
sinc
medic
effect
treat
sar
interrupt
transmiss
key
control
outbreak
simpl
public
health
measur
wear
surgic
mask
offer
effect
protect
transmiss
confirm
case
juli
public
health
lesson
learn
sar
epidem
prove
invalu
limit
spread
mer
case
worldwid
mer
first
recogn
septemb
octob
case
report
relat
death
date
largest
cluster
case
occur
outsid
middl
east
report
south
korea
may
index
case
businessman
develop
pulmonari
symptom
upon
return
trip
middl
east
total
case
identifi
death
mortal
rate
prove
migrat
capabl
viru
potenti
outbreak
worldwid
clinician
see
individu
return
middl
east
present
fever
pulmonari
symptom
within
day
travel
consid
mer
diagnosi
prompt
investig
diagnos
nasopharyng
cultur
public
health
control
method
initi
specif
treatment
vaccin
develop
date
infect
group
poorest
outcom
relat
mer
infect
young
year
elderli
year
immunocompromis
patient
multipl
comorbid
clinic
present
similar
sar
mer
longer
incub
period
greater
sever
pulmonari
symptom
even
higher
mortal
risk
case
mer
confirm
worldwid
date
direct
indirect
link
middl
saudi
arabia
proven
less
contagi
sar
far
although
expect
virul
viru
evolv
sar
mer
attract
much
media
coverag
forgotten
plagu
bacillu
yersinia
pesti
still
affect
great
number
peopl
year
pneumon
plagu
seen
endem
outbreak
certain
part
africa
sporad
case
occur
worldwid
histor
pandem
involv
bubon
swollen
pain
lymph
node
pneumon
plagu
centuri
centuri
centuri
howev
also
reemerg
limit
distribut
pneumon
plagu
occur
complic
bubon
plagu
form
capabl
transmiss
humantohuman
via
pulmonari
droplet
clinic
sequela
dri
cough
within
h
first
exposur
becom
product
hemoptysi
occur
sputum
becom
increasingli
bloodi
within
next
sign
certain
mortal
major
clinic
clue
diagnos
pneumon
plagu
travel
histori
rapid
onset
symptom
sometim
hour
asymptomat
fever
coughhemoptysi
bilater
pneumonia
patient
contagi
hemoptysi
develop
simpl
protect
measur
wear
mask
help
prevent
transmiss
last
report
outbreak
pneumon
plagu
madagascar
septemb
report
case
mortal
rate
plagu
endem
island
past
sever
affect
countri
world
develop
countri
risk
outbreak
diseas
sporad
case
occur
elsewher
four
patient
diagnos
juli
pneumon
plagu
colorado
unit
state
america
usa
index
patient
contract
diseas
pet
dog
death
occur
patient
rapidli
respond
antibiot
treatment
streptomycin
tetracyclin
sulphonamid
use
standard
antibiot
gentamicin
fluoroquinolon
altern
close
contact
given
prophylact
antibiot
monitor
symptom
plagu
bacillu
previous
use
biolog
warfar
centuri
yersinia
pesti
attract
agent
due
easi
access
simpl
cultur
need
transmiss
via
aerosol
import
point
note
plagu
outbreak
easili
control
simpl
public
health
measur
readili
avail
antibiot
howev
inappropri
manag
pneumon
plagu
almost
certainli
fatal
two
viral
infect
note
caus
outbreak
throughout
world
hantaan
caus
hantaviru
cardiopulmonari
syndrom
hp
nipah
virus
diseas
microscop
discov
zoonot
transmit
human
via
rodent
via
bat
pig
respect
rang
clinic
symptom
may
present
flulik
symptom
continu
onto
enceph
nipah
viru
pulmonari
failur
cardiogen
shock
hantavirusrel
infect
first
nipah
outbreak
malaysia
total
case
diagnos
mortal
rate
outbreak
spread
singapor
discov
viru
transmit
human
pig
result
cull
million
pig
control
outbreak
sinc
outbreak
occur
bangladesh
india
mortal
rate
around
case
present
pulmonari
symptom
cough
dyspnea
bilater
opac
cover
major
lung
field
chest
radiograph
higher
humantohuman
transmiss
rate
comparison
malaysian
outbreak
nipah
viru
readili
identifi
saliva
infect
patient
allow
easi
diseas
transmiss
outbreak
nipah
viru
south
east
asia
date
potenti
diseas
occur
countri
intermedi
host
fruit
bat
pteropodida
famili
extens
habitat
distribut
nativ
part
africa
northern
australia
treatment
limit
support
method
prevent
humantohuman
transmiss
import
stop
rapid
spread
studi
shown
antivir
drug
ribavirin
may
reduc
mortal
infect
present
hantavirus
bunyavirida
famili
identifi
caus
ill
human
sign
infect
rang
proteinuria
pulmonari
edema
frank
hemorrhag
ill
hp
like
occur
america
although
sporad
case
report
europ
diseas
like
transmit
area
sanit
poor
rural
farm
area
rodent
shed
viru
urin
drop
saliva
viru
transmit
human
via
pulmonari
droplet
first
report
outbreak
occur
usa
although
retrospect
seem
hantavirus
caus
fatal
pulmonari
ill
sinc
cluster
around
case
occur
area
southwest
usa
known
four
corner
clinician
identifi
seri
case
sever
acut
pulmonari
ill
affect
young
healthi
adult
noncardiogen
pulmonari
edema
develop
rapidli
date
case
hp
report
usa
viru
discov
yosemit
nation
park
potenti
hundr
travel
expos
infect
ten
case
hp
confirm
fatal
treatment
hantaviru
remain
support
intraven
fluid
use
caution
aggress
fluid
resuscit
like
acceler
progress
pulmonari
edema
failur
due
capillari
leakag
extracorpor
membran
oxygen
ecmo
treatment
dramat
reduc
mortal
rate
benefit
ribavirin
therapi
remain
undetermin
due
small
trial
number
date
one
hantaviru
evolv
transmit
via
humantohuman
contact
and
viru
name
geograph
discoveri
locat
accur
diagnosi
requir
high
degre
suspicion
consid
individu
present
recent
stay
north
south
america
rapidli
progress
pulmonari
symptom
andor
sign
risk
travel
contract
outbreak
diseas
remain
small
given
limit
geograph
distribut
present
risk
exposur
may
increas
sever
factor
tabl
activ
undertaken
close
contact
infect
individu
seek
appropri
pretravel
inform
recommend
clinician
import
uptod
knowledg
current
outbreak
occur
worldwid
relev
geographi
prompt
recognit
diagnosi
may
prevent
epidem
q
fever
caus
c
burnettii
worldwid
zoonot
diseas
outbreak
human
link
abattoir
carriag
c
burnettii
wind
farm
affect
anim
tick
also
act
reservoir
strictli
travelrel
ill
like
found
area
contamin
anim
wast
common
present
acut
febril
ill
nonspecif
sign
atyp
pneumonia
rural
travel
greatest
risk
factor
acquir
diseas
recent
q
fever
outbreak
occur
hungari
case
confirm
microimmunofluoresc
test
treat
week
tetracyclin
death
occur
effort
reduc
spread
q
fever
outbreak
includ
elimin
manur
disinfect
affect
farm
legionella
l
pneumophila
bacterium
caus
anyth
mild
febril
ill
potenti
fatal
form
pneumonia
known
legionnair
diseas
bacterium
ubiquit
environ
agent
caus
sporad
case
outbreak
outbreak
typic
link
contamin
water
system
condit
ideal
rapid
growth
organ
confirm
case
legionellosi
lisbon
portug
relat
contamin
industri
cool
tower
death
result
diseas
case
report
travel
develop
countri
europ
north
america
risk
individu
comorbid
elderli
smoker
immunosuppress
caus
inhal
aerosol
contain
bacterium
account
hospit
admiss
communityacquir
pneumonia
summer
autumn
peak
identif
affect
individu
urinari
pcr
treatment
macrolid
antibiot
pertussi
diphtheria
vaccineprevent
pulmonari
infect
poor
vaccin
uptak
led
recent
increas
case
develop
countri
import
therefor
take
full
vaccin
histori
return
travel
present
pulmonari
symptom
pertussi
worldwid
endemicepidem
diseas
outbreak
like
summerautumn
time
pertussi
thought
still
caus
around
death
per
year
children
year
age
although
uncertainti
estim
view
pauciti
reliabl
surveil
data
recent
increas
number
adolesc
young
adult
diagnos
highincom
countri
like
due
decreas
vaccin
uptak
rate
chang
vaccin
thought
acellular
vaccin
current
use
appear
shortliv
immun
lead
increas
infect
rate
macrolid
antibiot
given
affect
individu
prevent
spread
pertussi
diphtheria
present
acut
infecti
diseas
affect
upper
pulmonari
tract
caus
toxin
produc
bacterium
characterist
featur
membran
pharyng
fever
enlarg
anterior
cervic
lymph
node
edema
soft
tissu
neck
manifest
may
lead
airway
obstruct
bacterium
short
incub
period
untreat
individu
may
remain
infecti
week
pertussi
diphtheria
potenti
fatal
easili
prevent
leptospirosi
contract
either
direct
contact
infect
anim
urin
urinecontamin
water
found
worldwid
predominantli
found
tropic
subtrop
countri
raini
season
take
part
water
sport
risk
outbreak
report
among
canyon
particip
martiniqu
franc
increas
case
also
found
rural
part
countri
drink
water
easili
contamin
bacteria
exampl
well
poorli
construct
late
increas
number
case
note
europ
case
identifi
netherland
increas
comparison
previou
year
dutch
tourist
report
case
leptospirosi
tourist
acquir
diseas
thailand
clinic
cours
leptospirosi
variabl
symptom
myalgia
fever
cough
short
breath
weil
diseas
severest
form
may
develop
case
patient
progress
mild
flulik
symptom
sign
organ
failur
jaundic
spontan
bleed
high
degre
clinic
suspicion
leptospirosi
treatment
instig
diagnosi
serolog
via
microscop
agglutin
test
mat
antibodi
pcr
urin
antigen
test
may
take
around
day
onset
symptom
test
becom
posit
earli
mild
diseas
penicillin
tetracyclin
antibiot
effect
clinic
sever
weil
diseas
manifest
patient
may
requir
organ
support
littl
evid
antibiot
use
benefit
stage
total
confirm
case
leptospirosi
england
wale
acquir
oversea
major
relat
recreat
water
exposur
recreat
activ
camp
visit
rural
agricultur
area
lead
increas
risk
exposur
bacterium
caus
tularemia
typic
found
northern
hemispher
number
infect
case
underestim
underreport
outbreak
report
martha
vineyard
massachusett
usa
sweden
finland
last
year
francisella
tularensi
bacterium
respons
potenti
fatal
multisystem
diseas
reservoir
transmiss
via
tick
bite
fli
aerosol
water
exposur
food
identifi
subtyp
clinic
present
depend
biotyp
method
transmiss
port
entri
major
clinic
present
ulceroglandular
glandular
oculoglandular
oropharyng
pneumon
typhoid
pulmonari
featur
may
consist
lobar
pneumonia
pulmonari
effus
infiltr
hilar
lymphadenopathi
mortal
untreat
pneumon
tularemia
earli
diagnosi
treatment
key
prognosi
isol
bacterium
hazard
time
consum
laboratori
accept
sampl
cultur
agglutin
enzymelink
immunosorb
assay
elisa
test
diagnost
test
choic
aminoglycosid
bactericid
f
tularensi
recommend
cours
asid
f
tularensi
subspeci
tularensi
type
one
infecti
pathogen
known
man
properti
led
tularemia
identifi
potenti
weapon
bioterror
south
east
asia
northern
australia
particular
gramneg
organ
call
b
pseudomallei
respons
endem
melioidosi
diseas
commonli
initi
present
lowgrad
fever
atyp
pneumonia
rapidli
progress
multiorgan
dysfunct
mortal
rate
high
rang
gener
inappropri
antimicrobi
therapi
difficulti
cultur
bacterium
respons
mean
underreport
like
bacterium
resid
soil
water
transmiss
occur
mainli
percutan
inocul
inhal
exposur
like
occur
wet
season
affect
area
natur
catastroph
tsunami
sporad
case
infect
report
worldwid
manifest
latent
form
diseas
appear
ten
year
initi
exposur
number
intern
travel
continu
rise
particularli
rural
part
south
east
asia
northern
australia
could
lead
increas
number
travelrel
melioidosi
case
futur
earli
recognit
melioidosi
essenti
bacterium
resist
nearli
drug
given
communityacquir
pneumonia
current
treatment
recommend
ceftazidim
carbapenem
follow
erad
therapi
trimethoprim
sulfamethoxazol
least
month
recent
interest
vaccin
develop
due
public
health
bioweapon
concern
mous
model
vaccin
prove
success
date
test
human
tb
commonli
found
diseas
certain
part
world
risk
tb
travelrel
diseas
well
establish
studi
itali
conclud
half
return
travel
pneumonia
tb
present
febril
ill
pulmonari
symptom
tb
transmit
airplan
flight
baltimor
honolulu
show
passeng
posit
tuberculin
skin
test
sit
close
proxim
passeng
pulmonari
tb
overal
probabl
infect
symptomat
sourc
present
close
proxim
risk
link
longerterm
travel
area
higher
preval
proxim
affect
individu
risk
would
healthcar
worker
individu
visit
rel
tb
risk
longterm
travel
greater
month
local
popul
high
endem
area
dutch
studi
show
substanti
risk
longterm
travel
overal
incid
rate
per
personmonth
travel
howev
noon
studi
receiv
bacillu
bcg
vaccin
prior
travel
therefor
incid
amongst
vaccin
like
lower
recent
year
multidrugresist
tb
mdrtb
extens
drugresist
tb
xdrtb
becom
increasingli
import
public
health
problem
mani
countri
eastern
europ
part
asia
southern
africa
potenti
risk
transmiss
particularli
danger
form
tb
requir
renew
vigil
sinc
inform
sever
incid
patient
travel
shorthaul
air
mdrtb
xdrtb
case
close
famili
member
later
diagnos
diseas
potenti
risk
travel
possibl
given
infecti
natur
strain
tb
sinc
publish
guidelin
tb
air
travel
prevent
spread
diseas
main
advic
clinician
number
tb
infect
increas
mdrtb
xdrtb
diseas
risk
travel
contract
tb
small
increas
depend
vaccin
statu
length
travel
mode
travel
travel
destin
pulmonari
symptom
persist
despit
neg
standard
microscopi
cultur
sensit
test
tb
ad
differenti
diagnosi
list
investig
appropri
histoplasmosi
consid
travel
return
midwest
central
state
north
america
throughout
latin
america
central
western
africa
approxim
case
report
south
west
region
china
first
report
asia
coccidioidomycosi
valley
fever
long
recogn
travelrel
mycosi
endem
area
southern
california
arizona
central
south
america
return
travel
common
caus
flulik
ill
nonproduct
cough
pleurit
chest
pain
rule
symptom
continu
persist
underli
fungal
infect
consid
differenti
diagnosi
histoplasma
capsulatum
endem
north
latin
america
h
dubiosii
mainli
found
central
western
africa
organ
grow
soil
enrich
bat
bird
drop
human
infect
gener
occur
dust
inhal
disturb
soil
incub
period
rel
short
symptom
develop
within
week
exposur
reticulonodular
shadow
chest
radiograph
common
often
mediastin
lymphadenopathi
detect
histoplasma
antibodi
urin
serum
sensit
wide
use
diagnost
method
detect
coccidioidomycosi
coccidioid
immiti
similar
radiolog
cavit
pneumonia
may
seen
healthi
individu
fungal
infect
gener
selflimit
immunocompromis
andor
go
develop
sever
infect
system
complic
antifung
proven
effect
contrast
histoplasmosi
coccidioidomycosi
infect
gener
lead
acquir
immun
therefor
recurr
unlik
pulmonari
symptom
wheez
breathless
hemoptysi
eosinophilia
return
travel
prompt
investig
helminth
infect
may
present
loeffler
syndrom
result
larval
migrat
lung
tropic
pulmonari
eosinophilia
hypersensit
lymphat
filari
worm
specif
schistosomiasi
infect
katayama
syndrom
suspect
travel
return
africa
south
east
asia
fresh
water
exposur
present
fever
eosinophilia
dri
cough
urticari
rash
rare
pulmonari
present
helminth
infect
paragonimu
toxocariasi
dirofilariasi
consid
depend
travel
destin
incub
period
treatment
infect
gener
straightforward
caus
helminth
identifi
hydatidosi
echinococcosi
tapeworm
pulmonari
infiltr
major
case
asymptomat
follow
leak
hydatid
cyst
liver
patient
may
present
pleurit
chest
pain
breathless
cough
water
lili
sign
may
seen
chest
radiograph
surgeri
aspir
antiparasit
drug
requir
fulli
treat
infect
identifi
refer
review
search
differ
databas
pubm
ovid
medlin
embas
cochran
refer
relev
articl
follow
mesh
head
use
pulmonari
respiratori
tropic
diseas
travel
travel
return
travel
refer
assess
read
titl
abstract
articl
publish
english
includ
assess
refer
select
public
final
refer
list
gener
basi
relev
topic
cover
review
